Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead Sells 10,000 Shares

Zynex, Inc. (NASDAQ:ZYXI) CFO Daniel J. Moorhead sold 10,000 shares of the business’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $7.68, for a total value of $76,800.00. Following the completion of the sale, the chief financial officer now directly owns 19,738 shares in the company, valued at $151,587.84. This trade represents a 33.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Zynex Stock Performance

Zynex stock opened at $8.06 on Wednesday. Zynex, Inc. has a 1-year low of $7.15 and a 1-year high of $13.77. The company has a debt-to-equity ratio of 1.66, a current ratio of 3.94 and a quick ratio of 3.15. The firm has a market capitalization of $256.68 million, a P/E ratio of 53.73 and a beta of 0.53. The company’s 50-day moving average is $8.10 and its 200 day moving average is $8.18.

Analyst Ratings Changes

Several research analysts have recently weighed in on ZYXI shares. HC Wainwright restated a “buy” rating and issued a $17.00 price target on shares of Zynex in a research note on Friday, December 6th. Royal Bank of Canada reduced their price target on Zynex from $12.00 to $11.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th.

Institutional Investors Weigh In On Zynex

Hedge funds have recently made changes to their positions in the stock. Hotchkis & Wiley Capital Management LLC raised its stake in Zynex by 24.7% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 746,380 shares of the company’s stock valued at $6,090,000 after buying an additional 147,770 shares during the last quarter. Geode Capital Management LLC grew its holdings in Zynex by 6.7% during the third quarter. Geode Capital Management LLC now owns 425,509 shares of the company’s stock worth $3,473,000 after acquiring an additional 26,774 shares during the period. Millennium Management LLC grew its holdings in Zynex by 66.5% in the second quarter. Millennium Management LLC now owns 297,082 shares of the company’s stock valued at $2,769,000 after purchasing an additional 118,615 shares during the period. Royce & Associates LP grew its holdings in Zynex by 9.2% in the third quarter. Royce & Associates LP now owns 257,291 shares of the company’s stock valued at $2,099,000 after purchasing an additional 21,781 shares during the period. Finally, Janney Montgomery Scott LLC lifted its position in shares of Zynex by 10.3% in the fourth quarter. Janney Montgomery Scott LLC now owns 159,259 shares of the company’s stock valued at $1,276,000 after acquiring an additional 14,820 shares in the last quarter. 29.68% of the stock is currently owned by hedge funds and other institutional investors.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.